Stockscreener 앱 받기
0.64
4.92%
0.03
시간 외 거래:
.64
China Pharma Holdings Inc. 주식(CPHI)의 최신 뉴스
China Pharma Delays 10-K but Shows Narrowing Losses - tipranks.com
China Pharma Holdings Files For Non-Timely 10-K With US SEC - tradingview.com
China Pharma Holdings 10-K: Revenue $4.14M, Loss per Share $(0.74) - tradingview.com
Buy Signal: Can China Pharma Holdings Inc keep up with sector leadersBull Run & Trade Opportunity Analysis - baoquankhu1.vn
USA Stocks: Research Stocks from USA Stock Market - gurufocus.com
Risk Report: How does China Pharma Holdings Inc perform in inflationary periods2026 Growth vs Value & Capital Protection Trade Alerts - baoquankhu1.vn
China NT Pharma Group Announces Reduced Net Loss for 2025 After One-Off Non-Cash Gain – Profit Warning Update - Minichart
Market Outlook: How does China Pharma Holdings Inc perform in inflationary periodsForecast Cut & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Stock List: Research Stocks from Around the World - gurufocus.com
Aug Technicals: Can China Pharma Holdings Inc expand into new marketsQuarterly Investment Review & Stepwise Trade Signal Implementation - baoquankhu1.vn
Jobs Data: Is China Pharma Holdings Incs ROE strong enough2026 Year in Review & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Aug Drivers: Can China Pharma Holdings Inc keep up with sector leadersTrade Analysis Report & Low Volatility Stock Recommendations - baoquankhu1.vn
If You Invested $1,000 in China Pharma (CPHI) - Stock Titan
Quarterly Trades: How does China Pharma Holdings Inc perform in inflationary periodsMarket Sentiment Report & AI Enhanced Execution Alerts - baoquankhu1.vn
MGRX Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
China Medical System Holdings SEHK 867 Margin Decline Tests Bullish Growth Narrative - simplywall.st
Market Outlook: Will China Pharma Holdings Inc be affected by tariffs2026 Key Lessons & Safe Swing Trade Setups - baoquankhu1.vn
Assessing China Medical System (SEHK:867) Valuation After A Recent Share Price Pullback - simplywall.st
Investment Recap: How correlated is NCDL to the S P500Long Setup & Weekly Momentum Stock Picks - baoquankhu1.vn
Bearish Setup: How does China Pharma Holdings Inc perform in inflationary periods2026 Winners & Losers & Low Drawdown Investment Strategies - baoquankhu1.vn
Volume Recap: What are the analyst revisions for Amdocs LimitedIs CTEV stock a good investment in YEARProduct Launch & AI Based Buy and Sell Signals - baoquankhu1.vn
Can China Pharma Holdings Inc lead its sector in growth2026 Momentum Check & Target Return Focused Picks - baoquankhu1.vn
Will Pony AI Inc. Depositary Receipt stock continue dividend increases2026 Support & Resistance & Reliable Intraday Trade Plans - Naître et grandir
How GreenTree Hospitality Group Ltd. American stock performs during market turbulencePortfolio Risk Report & Weekly Return Optimization Plans - Naître et grandir
Volume Report: Is Central Plains Bancshares Inc backed by strong institutional buyingRisk Management & Community Consensus Trade Alerts - baoquankhu1.vn
Is Southland Holdings Inc. Equity Warrant stock a dividend growth opportunityIPO Watch & Risk Controlled Daily Trade Plans - Naître et grandir
Fed Watch: Is China Pharma Holdings Incs ROE strong enoughJuly 2025 Trade Ideas & Stepwise Trade Execution Plans - baoquankhu1.vn
Trade Recap: Can China Pharma Holdings Inc expand into new marketsJuly 2025 Intraday Action & Community Consensus Trade Signals - baoquankhu1.vn
China Pharma Expands R&D Portfolio With Patent Acquisition - TipRanks
Quarterly Risk: Can China Pharma Holdings Inc keep up with sector leadersJuly 2025 WrapUp & Fast Gain Stock Trading Tips - baoquankhu1.vn
getLinesFromResByArray error: size == 0 - mfd.ru
Naproxen Patches Market Growth Fueled by Shift from Oral Nsaids, Forecast to 2035News and Statistics - IndexBox
CPHI Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
GLMD PE Ratio & Valuation, Is GLMD Overvalued - Intellectia AI
Inflation Data: Is Blackstone Inc affected by consumer sentimentQuarterly Earnings Summary & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Risk Check: Is China Pharma Holdings Inc part of any ETFQuarterly Growth Report & Smart Investment Allocation Insights - baoquankhu1.vn
Risk Analysis: Can NESRW lead its sector in growthShare Buyback & Trade Opportunity Analysis - baoquankhu1.vn
BIT Capital GmbH Reduces Holdings in BridgeBio Pharma, Inc. $BBIO - Defense World
CPHI Should I Buy - Intellectia AI
Winners Losers: Is GoldMining Inc part of any ETFMarket Sentiment Summary & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
The China factor: US pharma group campaigns for increased competitiveness - Yahoo Finance
PAPLD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
AI Drug Discovery Push And New Kidney Drug Trial Could Be A Game Changer For China Medical System Holdings (SEHK:867) - simplywall.st
Profit Review: Should I set a stop loss on SGRPLayoff News & Technical Buy Zone Confirmation - baoquankhu1.vn
00863 Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Most and least shorted healthcare stocks with up to $2B market cap - Seeking Alpha
Plasma Fractionation Market Size, Share, Trend, Scope Report 2026 to 2035 - Insightace Analytic
Can China Pharma Holdings Inc. stock maintain growth trajectory2025 Investor Takeaways & Long-Term Safe Return Strategies - mfd.ru
Will China Pharma Holdings Inc. stock maintain momentum in 2025Gap Up & Verified Entry Point Detection - mfd.ru
What margin trends mean for China Pharma Holdings Inc. stockJuly 2025 Trends & Technical Pattern Based Signals - mfd.ru
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
China Medical System Expands AI Drug Pipeline As Valuation Gap Persists - simplywall.st
Published on: 2026-02-12 19:55:00 - mfd.ru
Is Gold Royalty Corp. currently under institutional pressure2025 Top Gainers & Stock Portfolio Risk Control - mfd.ru
Is China Pharma Holdings Inc. stock trending bullish2025 Key Highlights & AI Driven Price Predictions - mfd.ru
What’s next for Athira Pharma Inc. stockCPI Data & Pattern Based Trade Signal System - mfd.ru
Can China Pharma Holdings Inc. expand its profit marginsTrade Risk Report & Long-Term Safe Investment Ideas - mfd.ru
China Pharma Acquires Topiroxostat Patent Via Equity Issuance - The Globe and Mail
China Pharma to acquire patent through $8.82 million stock issuance By Investing.com - Investing.com UK
China Pharma to acquire patent through $8.82 million stock issuance - Investing.com Nigeria
Risk Check: Is PGEN stock a hidden gemPortfolio Risk Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Aug Reactions: Can China Pharma Holdings Inc stock outperform in a bear marketJuly 2025 Spike Watch & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Ascentage Pharma Receives Clearance from China’s CDE for New Drug - Yahoo Finance
Ascentage Pharma Group International Announces IND Clearance by the China CDE for BTK Degrader APG-3288 - marketscreener.com
Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288 - Yahoo Finance
2.74%
0.62%
자본화:
|
볼륨(24시간):